Immunohistochemical expression of protein p53 in neoplasms of the mammary gland in bitches

• Autorzy: Rodo A. , Malicka E.
• Języki publikacji: EN

Abstrakty

EN

The aim of the study was to investigate the presence of protein p53 in correlation with other tumor traits: histological type, tumor grade and proliferative activity. Material for the investigation comprised mammary gland tumours collected from dogs, the patients of veterinary clinics, during surgical procedures, and archival samples. Altogether 21 adenomas, 31 complex carcinomas, 35 simple carcinomas and 12 solid carcinomas were qualified for further investigation. No proteinp53 expression was found in adenomas. Cancers show positive reaction in 32.5%. The highest percent of p53 positive neoplasms was observed in solid carcinomas and neoplasms with the highest degree of histological malignancy. The smallest number showing this expression was observed in adenomas and the highest was characteristic for solid carcinomas. Considering the tumour grading, it was found that an increase in neoplasm malignancy was positively correlated with the number of the cells showing the expression of protein p53. The differences were statistically significant. Statistically significant positive correlations were observed between the proliferative activity and protein p53 expression. Higher accumulation of protein p53 in more malignant neoplasms suggests that mutations of protein p53 can be responsible for higher proliferation in neoplasms with advanced progression of malignancy.

Słowa kluczowe

EN

dog; bitch; mammary gland; immunohistochemistry; p53 protein; tumour; surgical procedure; adenoma; carcinoma; p53 expression; cancer; animal disease; proliferative activity

• Wydawca: -
• Czasopismo: Polish Journal of Veterinary Sciences
• Rocznik: 2008
• Tom: 11
• Numer: 2
• Opis fizyczny: p.89-95,fig.,ref.

Twórcy

autor

Rodo A.

• Warsaw University of Life Sciences, Nowoursynowska 159c, 02-766 Warsaw, Poland

autor

Malicka E.

Bibliografia

• Allred DC, Clark GM, Elledge R, Fuqua SAW, Brown RW, Chamness GC, Osborne CK, McGuire WL (1993) Asso­ciation of p53 protein expression with tumor cell prolifer­ation rate and clinical outcome in node- negative breast cancer. J Natl Cancer Inst 85: 200-206.
• Benjamin SA, Lee AC, Saunders WJ (1999) Classification and behaviour of canine mammary epithelial neoplasms based on life-span observation in beagles. Vet Pathol 36: 423-436.
• Cheng L, Leibovich BC, Bostwick DG (1999) p53 Alteration in regional lymph node métastasés from prostate carcino­ma: a marker for progression. Cancer 85: 2455-2459.
• Devilee P, van Leeuwen IS, Vosten A, Rutteman GR, Vos JH, Cornelisse CJ (1994) The canine p53 gene is subject to somatic mutations in thyroid carcinoma. Anticancer Res 14: 2039-2046.
• Domagala W, Harezga B, Szadowska A, Makiewski M, Weber K, Osborn M (1993) Nuclear p53 protein accu­mulates preferentially in medullary and high- grade duc­tal but rarely in lobular breast carcinoma. Am J Pathol 142(3): 669-674.
• Ikeda G, Isaji S, Chandza-Das B, Watanabe M, Kawarada Y (1999) Prognostic significance of biologic factors in squamous cell carcinoma of the esophagus. Cancer 86: 1396-1405.
• Johnson SA, Couto CG, Weghorst CM (1998) Mutation of the p53 tumor suppressor gene in spontaneously occurring osteosarcomas of the dog. Carcinogenesis 19: 213-217.
• Elledge RM (1996) Assesing p53 status in breast cancer prognosis: where should you put the thermometer if you think your p53 is sick? J Natl Cancer Inst 88: 141-143.
• Gamblin RM, Sagartz JE, Guillermo Couto C (1997) Overexpression of p53 tumor suppressor in spontaneous­ly arising neoplasms of dogs. Am J Vet Res 58: 857-863.
• Gilbertson S, Kurzman I, Zachrau R, Hurritz A, Black M (1983) Canine mammary epithelial neoplasms: bio­logic implication of morphologic characteristics assessed in 232 dogs. Vet Pathol 20: 127-142.
• Guevara- Fuijita M, Loechel R, Venta PJ, Yuzbasiyan-Gur- kan V, Brewe GJ (1996) Chromosomal assigment of seven genes on canine chromosomes by fluorescence in situ hybridization. Mamm Genome 7: 268-270.
• Guo Y, Ma J, Wang J, Che X (1994) Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Cancer Res 54: 1561-1565.
• Hall PA, Lane DP (1994) p53 in tumour pathology: can we trust immunohistochemistry-revisited! J Pathol 172: 1-4.
• Hermeking H, Fick D (1994) Mediation of c-myc-induced apoptosis by p53. Science 265: 2091-2093.
• Hurlimann J, Chaubert P, Banhattar J (1994) p53 gene al­terations and p53 protein accumulation in infiltrating ductal breast carcinomas: correlation between im­munohistochemical and molecular biology techniques. Mod Pathol 7: 423-428.
• Kahlenberg MS, Staler DL, Rodrigez-Bigas Ma, Weber TK, Driscol DL, Anderson GR, Petrelli NJ (2000) p53 tumor suppressor gene mutation predict decreased survival of patients with sporadic colorectal carcinoma. Cancer 88: 1814-1819
• Kaserer K, Schmaus J, Wrba F, Bethge V, Migschitz B, Fasching S, Walch A, Herbst F, Teleky B (2000) Staining patterns of p53 immunohistochemistry and their biologi­cal significance in colorectal cancer. J Pathol 190: 450.
• van Leeuwen IS, Hellmen E, Cornelisse CJ, van den Burgh, Ruttcman GR (1996) p53 Mutation in mammary tumor cell lines and corresponding tumor tissues in the dog. Anticancer Res 16: 3737-3744.
• Lipponen P, Eskelinen M, Hietala K, Syrjanen K (1994) Expression of proliferating cell nuclear antigen (PC10), p53 protein and c-erbB-2 in renal adenocarcinoma. Int J Cancer 57: 275-280.
• Lonardo F, Ueda T, Huvos AG, Heaky J, Ladanyi M (1997) p53 and MDM2 alterations in osteosarcomas: correlation with clinicopathologic features and proliferative rate. Cancer 79: 1541-1547.
• Loukopoulos P, Thornton JR, Robinson WF (2003) Clinical and pathologic relevance of p53 index in canine osseous tumors. Vet Pathol 40: 237-248.
• Lowe SW, Ruley HE, Jacks T, Hausman DE (1993) p53- dependent apoptosis modulated by cytotoxity of antican­cer agents. Cell 74: 957-968.
• Ludlow JW (1993) Interactions between SV40 large tumor antigen and the growth suppressor proteins pRB and p53. FASEB J 7: 866-871.
• Malicka E, Piusiiiski W, Sendecka H, Bielecki W, Osinska B, Lenartowicz-Kubrat Z (1996) Nowotwory psow stwier- dzane w badaniach anatomopatologicznych w latach 1985-1993. Med Weter 2: 103-106.
• Maxwell SA, Roth JA (1993) Binding of cellular proteins to a conformational domain of tumor suppressor protein p53. Oncogene 8: 8421-8426.
• Mayr B, Dressier A, Reifinger M, Feil C (1998) Cytogenetic alterations in eight mammary tumors and tumor- sup­pressor gene p53 mutation in one mammary tumor from dogs. AmVet Res 59: 69-78.
• Mayr B, Schellander K, Schlleger W, Reifinger M (1994) Sequence of exon of the canine p53 gene - mutation in a papilloma. Br Vet J 150: 81-84.
• Mendoza S, Konishi T, Dernell WS (1998) Status of the p53, Rb and MDM2 genes in canine osteosarcoma. Antican­cer Res 18: 4449-4453.
• Michalovitz D, Halevy O, Orten M (1990) Conditional inhi­bition of transformation of cell proliferation by a tem­perature- sensitive mutant of p53. Cell 62: 671-680.
• Misdorp W (2002) Tumors of the mammary gland. In: Meuten DJ (ed) Tumors in domestic animals. Iowa State Press, pp 575-606.
• Misdorp W, Else RW, Hellmen E, Lipscomb TP (1999) His­tological classification of mammary tumors of the dog and cat. Bulletin of the World Health Organization, Geneva.
• Monand J, Zambetti GP, Olson DC, George D, Levine AJ (1992) The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53- mediated transac­tivation. Cell 69: 1237-1245.
• Moulton JE (1990) Tumors of the mammary gland. In: Moulton JE (ed) Tumors in domestic animals, University of California Press, pp 518-552.
• Muto T, Wakui S, Takahashi H, Maekawa S, Masaoka T, Ushigome S, Furusato M (2000) p53 Gene Mutations occurring in spontaneous bening and malignant mam­mary tumors of the dog. Vet Pathol 37: 248-253.
• Nakopoulou LL, Alexiadou A, Theodoropoulos GE, Lazaris ACH, Tzonou A, Keramopoulos A (1996) Prognostic significance of the co expression of p53 and c-erbB-2 pro­teins in breast cancer. J Pathol 179: 31-38.
• Nieder C, Petersen S, Petersen C, Thames HD (2000) The challenge of p53 as prognostic and predictive factor in gliomas. Cancer Treat Rev 26: 67-73.
• Rungsipipat A (1999) Immunohistochemical analysis of c-yes and c-erbB-2 oncogene products and p53 tumor suppressor protein in canine mammary tumors. J Vet Med Sci 61(1): 27-32.
• Saitoh S, Cunnigham J, De Vries EM, McGovern RM, Schroder JJ, Hartmann A, Blaszyk H, Wold LE, Schaid D, Sommer SS (1994) p53 gene mutations in breast can­cers in Midwestern US women: null as well as missense- type mutations are associated with poor prognosis. On­cogene 9: 2869-2875.
• Shahin MS, Hughes JH, Sood AK, Buller RE (2000) The prognostic significance of p53 tumor suppressor gene al­terations in ovarian carcinoma. Cancer 89: 2006-2017.
• Sokołowska J, Cywińska A, Malicka E (2005) p53 expression in canine lymphoma. J Vet Med A Physiol Pathol Clin Med 52: 172-175
• Soussi T, Legros Y, Lubin R, Ory K, Schlichtholz B (1994) Multifactorial analysis of p53 alteration in human cancer. Int J Cancer 57: 1-9.
• Walker DR, Bond JP, Tarone RE, Harris CC, Makalowski W, Boguski MS, Greenblatt MS (1999) Evolutionary conservation and somatic mutation hotspots maps of p53: correlation with p53 protein structural and functional features. Oncogene 19: 211-218.
• Veldhoen N, Milner J (1998) Isolation of canine p53 cDNA and detailed characterization of the full length canine p53 protein. Oncogene 16: 1077-1084.
• Veldhoen N, Stewart J, Brown R, Milner J (1998) Mutations of the p53 gene in canine lymphoma and evidence for germ line p53 mutations in the dog. Oncogene 16: 249-255.
• Veldhoen N, Watterson J, Brash M, Milner J (1999) Identi­fication of tumor- associated and germ line p53 mutation in canine mammary cancer. Br J Cancer 81: 409-415.